Skip to main content
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Biosimilars
Biosimilars
Biosimilars—Are We There Yet?
Read More
Biosimilars
,
Cardiometabolic Health
,
FDA Approvals
FDA OKs Rapid-Acting Insulin Biosimilar Product
Read More
Biosimilars
Oncologists’ Common Misconceptions About Biosimilars Revealed in a Recent Survey
Read More
Review Article
,
Biosimilars
,
Practice Management
Implementation Strategies of Biosimilars in Healthcare Systems: The Path Forward
Raymond K. Cross, MD, MS; Amy L. Stewart, MSN, RN, FNP-C; Colin C. Edgerton, MD, FACP, FACR, RhMSUS; Bhavesh Shah, RPh, BCOP; John A. Welz, MPH; Jonathan Kay, MD
Read More
FDA Approvals
,
Biosimilars
,
Dermatology
Tremfya (Guselkumab), a Novel One-Press Patient-Controlled Injection, Approved for Moderate-to-Severe Plaque Psoriasis
Loretta Fala
Read More
Biosimilars
Is a Biologic Produced 15 Years Ago a Biosimilar of Itself Today?
Read More
Results 1 - 6 of 6
